Insider Shareholders with Direct Ownership of Galera Therapeutics, Inc. (GRTX)
This section provides a comprehensive overview of the insiders with direct ownership of Galera Therapeutics, Inc. (GRTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Galera Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Yair Schneid
> 10% Shareholder |
932,402 | 0 | 8,043,203 $321,728 | 6 |
Feb 08, 2024
Added 1.83%
|
| 0 | 1,075,106 | 2,467,961 $98,718 | 14 |
Jun 19, 2020
Reduced 28.86%
|
|
|
Novo Holdings
> 10% Shareholder |
3,409,021 | 950,000 | 2,459,021 $98,360 | 3 |
Feb 18, 2021
Reduced 16.9%
|
|
Mel Sorensen
President and CEO |
317,015 | 67,015 | 265,029 $10,601 | 3 |
Aug 16, 2024
Reduced 20.18%
|
|
Robert A Beardsley
Chief Operating Officer |
40,000 | 0 | 108,191 $4,327 | 3 |
Nov 21, 2022
Added 8.46%
|
| 60,000 | 0 | 60,000 $2,400 | 5 |
Dec 17, 2021
Added 25.0%
|
|
|
Mark Bachleda
Chief Commercial Officer |
11,000 | 0 | 11,000 $440 | 1 |
Mar 16, 2023
Added 50.0%
|
|
Chris Degnan
Chief Financial Officer |
10,000 | 0 | 10,000 $400 | 1 |
Mar 13, 2023
Added 50.0%
|
| 2,325 | 4,000 | 2,325 $93 | 2 |
Jul 18, 2022
Reduced 63.24%
|
|
|
Jon T Holmlund
Chief Medical Officer |
60,636 | 60,636 | 0 $0 | 8 |
Sep 01, 2021
Reduced 100.0%
|
|
Joel F. Sussman
Chief Accounting Officer |
20,000 | 20,000 | 0 $0 | 4 |
Nov 13, 2020
Reduced 100.0%
|